Table 1 Demographics and baseline characteristics of COVID-19 patients with cardiac injury.
From: Key factors leading to fatal outcomes in COVID-19 patients with cardiac injury
Characteristic | No. (%) | |||
|---|---|---|---|---|
Total (N = 173) | Nonsurvivors (N = 87) | Survivors (N = 86) | p value | |
Age, median (IQR), years | 73 (64–80.5) | 76 (65–83) | 70.5 (61.75–78.25) | .010 |
Sex | ||||
Female | 62 (35.8%) | 29 (33.3%) | 33 (38.4%) | .611 |
Male | 111 (64.2%) | 58 (66.7%) | 53 (61.6%) | .635 |
Comorbidity | ||||
Hypertension | 72 (41.6%) | 41 (47.1%) | 31 (36%) | .139 |
Coronary heart disease | 29 (16.8%) | 18 (20.7%) | 11 (12.8%) | .164 |
Chronic kidney disease | 8 (4.6%) | 3 (3.4%) | 5 (5.8%) | .459 |
Diabetes | 29 (16.8%) | 13 (14.9%) | 16 (18.6%) | .519 |
Heart failure | 1 (0.6%) | 0 (0.0%) | 1 (1.2%) | .313 |
Chronic obstructive pulmonary disease | 15 (8.6%) | 9 (10.3%) | 6 (7.0%) | .431 |
Chronic liver disease | 2 (1.2%) | 1 (1.1%) | 1 (1.2%) | .993 |
Cerebrovascular disease | 15 (8.7%) | 10 (11.5%) | 5 (5.8%) | .184 |
Cancer | 2 (1.2%) | 2 (2.3%) | 0 (0.0%) | .157 |
Signs and symptoms | ||||
Fever (temperature ≥ 37.3℃) | 126 (72.8%) | 68 (78.2%) | 58 (67.4%) | .113 |
Cough | 97 (56.1%) | 39 (44.8%) | 58 (67.4%) | .003 |
Fatigue or myalgia | 34 (19.6%) | 21 (24.1%) | 13 (15.1%) | < .001 |
Shortness of breath | 60 (34.7%) | 34 (39.1%) | 26 (30.2%) | .135 |
Chest pain | 27 (15.6%) | 19 (21.8%) | 8 (9.3%) | .023 |
Dizziness or headache | 10 (5.8%) | 4 (4.6%) | 6 (7.0%) | .503 |
Nausea and vomiting | 6 (3.5%) | 3 (3.4%) | 3 (3.5%) | .989 |
Hemoptysis | 39 (22.5%) | 18 (20.7%) | 21 (24.4%) | .557 |
Diarrhea | 16 (9.2%) | 11 (12.6%) | 5 (5.8%) | .121 |
Bilateral distribution of patchy shadows or ground-glass opacity | 133 (76.9%) | 67 (77.0%) | 66 (76.7%) | .967 |
